Medium-term immunogenicity of three doses of BNT162b2 and CoronaVac in Hong Kong neuromuscular disease patients
The durability of the immunogenicity elicited by three doses of mRNA-based BNT162b2 and whole-virus inactivated CoronaVac in patients with neuromuscular diseases, particularly those on immunosuppressive drugs and variants of concern, has not been well-established. Our goal was to evaluate medium-ter...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Taylor & Francis Group
2024-12-01
|
| Schriftenreihe: | Human Vaccines & Immunotherapeutics |
| Schlagworte: | |
| Online-Zugang: | https://www.tandfonline.com/doi/10.1080/21645515.2024.2424615 |
| Tags: |
Keine Tags, Fügen Sie das erste Tag hinzu!
|